News

Men with multiple sclerosis (MS) show differences in health-related behaviors based on how much they value certain masculine ideals, according to a new study that suggests possible negative effects of masculinity in terms of seeking medical care. Results from the study — which specifically focused on white males in…

People with multiple sclerosis (MS) who are on therapies that deplete antibody-producing B-cells can mount an effective T-cell immune response to COVID-19 vaccination, a new study shows. The findings suggest that the vaccines strongly activate other parts of the immune system that are helpful in fighting the virus,…

Robotic-assisted gait training (RAGT) may be the most effective form of physical exercise for improving mobility among people with severe multiple sclerosis (MS), according to a recent review study. Other exercise types, such as conventional walking, treadmill training, and yoga, may also be feasible and effective, however, the researchers…

Pasithea Therapeutics investigational multiple sclerosis vaccine, PAS002, effectively delayed disease onset and reduced disease severity in a mouse model of the neurodegenerative condition, according to data from a preclinical study. The vaccine, which is designed to promote immune tolerance to a specific myelin protein, also reduced the severity…

After a relapse involving optic neuritis, or inflammation in the nerves connecting the eyes and brain, measurements of retinal thinning may predict the likelihood of full recovery from future relapses in people with multiple sclerosis (MS), a study suggests. The measurement could identify subclinical nerve cell damage that remains…

Transcutaneous tibial nerve stimulation (TTNS), a procedure sending an electric current through the skin to nerves in the legs, is generally safe and feasible in people with overactive bladder due to multiple sclerosis (MS), according to a proof-of-concept study. Though the study was not designed to test the efficacy…

People with multiple sclerosis (MS) are absent from their places of employment nearly twice as often as individuals without the neurodegenerative disease, according to a new study based on U.S. data. The results also showed missing work is significantly more common for MS patients who are unmarried, experience…

Tysabri (natalizumab) outperforms other disease-modifying therapies (DMTs) in its ability to lessen a range of patient-reported symptoms in people with multiple sclerosis (MS), according to data from a large real-world study. These symptoms include balance difficulties, sensory problems, feelings of anxiety, bladder problems, vision problems, and…

Adding a specialized nurse practitioner (NP) to a neurologist-based standard care team was found to significantly lessen depression and anxiety in patients with multiple sclerosis (MS), according to data from a six-month study in Canada. People with multiple sclerosis — dubbed “PwMS” by researchers — who received the add-on…

By engaging a variety of stakeholders from across the multiple sclerosis (MS) community, researchers in the U.S. Deep South were able to enroll more than 800 patients to a clinical trial in just over two years in what’s considered the largest study of an exercise intervention in MS patients…

A team of researchers has created a three-dimensional (3D) map of the lymphatic vessels that drain the brain, and demonstrated that these vessels are organized similarly in mice and in humans. The researchers propose measuring these vessels using MRI scans could “allow longitudinal imaging of disease progression that may be…

Switching from a standard monthly course of Tysabri (natalizumab) to an extended-interval dosing administered every six weeks does not seem to increase neuronal damage in people with multiple sclerosis (MS), a study found. While individual blood levels of neurofilament light chain (NfL), a biomarker of nerve damage, did…

Variations in more than a dozen genes on the sex-determining X chromosome are more common among those with multiple sclerosis (MS) than in the general population, according to an analysis of nearly 500,000 people in the U.K. Many of these genes are known to play roles in biological processes…

Autologous hematopoietic stem cell transplant (aHSCT), a procedure that aims to “reset” the immune system, generally reduces disability and relapse rates in people with multiple sclerosis (MS), according to a new meta-analysis. “Current data encourage a broader application of AHSCT for treating patients with MS while still considering…

A set of receptors involved in dopamine signaling may play a key role in the activation of astrocytes, nerve support cells that contribute to the inflammation that drives multiple sclerosis (MS), according to a study in a mouse model of the neurodegenerative disease. Mice lacking these receptors — called dopamine…

Two years of treatment with Ocrevus (ocrelizumab) outperformed Rebif (interferon beta-1a) at preventing myelin loss in people with relapsing multiple sclerosis (MS), according to a new analysis of data from the OPERA II clinical trial. Ocrevus’ protection against demyelination was observed both in MS lesions,…

An international team of scientists is calling for more rigorous studies to test whether exercise can help protect the nervous system from damage in people with multiple sclerosis (MS). The scientists argue clinical trials that have evaluated exercise in MS have marked flaws in their design, making…

Providing electrical stimulation to the vagus nerve, a large nerve that plays important roles in modulating nonconscious bodily processes like digestion and heart rate, can improve motor learning in mice, a new study shows. The approach specifically helped the animals learn motor tasks faster and achieve better performance levels in…

People with multiple sclerosis (MS) have significantly higher and potentially damaging blood levels of zinc and a greater activity of the superoxide dismutase (SOD) enzyme than is evident in people without MS or similar diseases, a study reported. SOD is an enzyme that requires zinc to function properly, including…

When Sarah Garcia was diagnosed with the relapsing-remitting form of multiple sclerosis (MS) at age 13, she didn’t know any other young Latino women with the neurodegenerative disorder. Garcia grew up in a tight-knit Hispanic community in Socorro, Texas, near El Paso. Most of her doctors were white,…

A number of genetic variations related to vitamin D metabolism were not significantly associated with the severity of multiple sclerosis (MS), according to a recent study. The study, “Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings,” was published in Genes. In MS, the body’s immune…

Cionic has collaborated with the multidisciplinary design firm fuseproject to further develop its artificial intelligence-powered, wearable Neural Sleeve, which improves mobility for those living with conditions such as multiple sclerosis (MS). The partnership with Yves Behar and his firm fuseproject resulted in a design that focuses on…

Calyx and Qynapse have joined forces to expand the use of artificial intelligence (AI)-based neuroimaging tools in clinical trials of treatment candidates for conditions affecting the central nervous system (CNS), or the brain and spinal cord. This is expected to help advance therapy development for multiple sclerosis…

Breakthrough Health, a startup company that created the Emilyn mobile app to help people with multiple sclerosis (MS) manage their disease, has been acquired by Mymee to further its support to the MS community. A provider of specialized support for those with autoimmune diseases and long-term symptoms…

A new machine learning strategy was able to differentiate tremor specific to multiple sclerosis (MS) from tremor related to other diseases, with more than 90% accuracy, according to a new study. “The proposed method, with high classification accuracy and strong correlations of [tremor] features to clinical outcomes, has clearly…

The U.S. Food and Drug Administration (FDA) has agreed to review an application requesting that Polpharma Biologics‘ natalizumab, a biosimilar of Tysabri, be approved to treat relapsing forms of multiple sclerosis (MS). Its intended U.S. use is for the same indications as the approved name-brand medicine, covering clinically isolated…

Exercise prior to being diagnosed with multiple sclerosis (MS) was associated with less depression and anxiety among patients, likely due to a reduction in the levels of an inflammatory molecule called interleukin-2 (IL-2), a study revealed. “This finding supports the notion that exercise in the early stages may act…

Most available studies suggest a connection between childhood trauma and multiple sclerosis (MS), from earlier symptom onset to potentially poorer outcomes, but more research is needed to understand this association, a review paper highlights. While several high-quality studies have been published, the scientists noted “considerable heterogeneity [variability] in methodology, including inconsistencies…

Digoxin, an approved medication for certain heart conditions, promoted the repair of myelin — the protective sheath around nerve fibers that is progressively lost in multiple sclerosis — in mouse models of the disease, a study reports. Combining digoxin with an experimental immune-modulating therapy was more effective at promoting myelin…

Leading a healthy cognitive and physically active lifestyle, including having a normal body weight and well-controlled blood pressure, may increase brain reserve — the brain’s ability to adapt after damage — and delay disability progression in multiple sclerosis (MS), according to a new study. The study, “Lifestyle factors…